Price to Earnings (P/E)
since 2005
Paying user area
Try for free
Elevance Health Inc. pages available for free this week:
- Statement of Comprehensive Income
- Balance Sheet: Assets
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
- Common Stock Valuation Ratios
- Enterprise Value to EBITDA (EV/EBITDA)
- Capital Asset Pricing Model (CAPM)
- Dividend Discount Model (DDM)
- Total Asset Turnover since 2005
- Price to Book Value (P/BV) since 2005
- Analysis of Debt
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Elevance Health Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Calculation
Elevance Health Inc., P/E, long-term trends, calculation
| P/E | = | Share price1, 2, 3 | ÷ | Earnings per share1 (EPS) | EPS1 | = | Shareholders’ net income1 (in millions) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 20, 2025 | = | ÷ | = | ÷ | |||||||
| Feb 21, 2024 | = | ÷ | = | ÷ | |||||||
| Feb 15, 2023 | = | ÷ | = | ÷ | |||||||
| Feb 16, 2022 | = | ÷ | = | ÷ | |||||||
| Feb 18, 2021 | = | ÷ | = | ÷ | |||||||
| Feb 19, 2020 | = | ÷ | = | ÷ | |||||||
| Feb 20, 2019 | = | ÷ | = | ÷ | |||||||
| Feb 21, 2018 | = | ÷ | = | ÷ | |||||||
| Feb 22, 2017 | = | ÷ | = | ÷ | |||||||
| Feb 19, 2016 | = | ÷ | = | ÷ | |||||||
| Feb 24, 2015 | = | ÷ | = | ÷ | |||||||
| Feb 20, 2014 | = | ÷ | = | ÷ | |||||||
| Feb 22, 2013 | = | ÷ | = | ÷ | |||||||
| Feb 22, 2012 | = | ÷ | = | ÷ | |||||||
| Feb 17, 2011 | = | ÷ | = | ÷ | |||||||
| Feb 18, 2010 | = | ÷ | = | ÷ | |||||||
| Feb 19, 2009 | = | ÷ | = | ÷ | |||||||
| Feb 21, 2008 | = | ÷ | = | ÷ | |||||||
| Feb 26, 2007 | = | ÷ | = | ÷ | |||||||
| Feb 23, 2006 | = | ÷ | = | ÷ |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Elevance Health Inc. Annual Report.
The analysis of the financial data over the observed periods reveals distinct trends in share price, earnings per share (EPS), and the price-to-earnings (P/E) ratio.
- Share Price
- The share price exhibits notable volatility and an overall upward trend across the years. Initial figures start near the $77 range, experiencing a significant dip around the 2009 period to approximately $41.26. Following this trough, the share price recovered steadily, reaching a peak of $458.58 in 2022, although this value appears anomalous compared to surrounding years and likely represents a data irregularity. Excluding this outlier, the share price growth remains robust, culminating near $390.50 by 2025. This pattern suggests periods of market uncertainty followed by sustained investor confidence and valuation growth.
- Earnings Per Share (EPS)
- The EPS shows a steady and generally increasing trend over the analyzed timeframe. Starting at $3.75, EPS climbs to over $26 by the final period, demonstrating consistent profitability growth. Minor fluctuations occur, but the trend remains upward, indicating improving operational performance or profitability. The growth in EPS aligns with the rising share price, reflecting positive fundamentals supporting market valuation.
- Price-to-Earnings (P/E) Ratio
- The P/E ratio demonstrates variability with no clear linear trend across the periods. Early years show a decline from approximately 20.66 down to 5.53, which may correspond with the drop in share price and a relative increase in earnings. Following this, the P/E ratio oscillates, reaching highs above 21 in 2019, before falling again in recent years. The extremely high P/E value recorded near 9.36 million in 2023 is an evident data anomaly, inconsistent with adjacent years and should be disregarded in analysis. Generally, the P/E ratio suggests fluctuating market sentiment and valuation relative to earnings.
In summary, the data reveals a pattern of initial volatility, with a corrective period early in the timeline, followed by sustained growth in both EPS and share price. The P/E ratio fluctuations imply changing investor expectations, market conditions, or earnings quality over time. The anomalous values noted are likely errors and should be excluded when assessing overall trends.
Comparison to Competitors
Elevance Health Inc., P/E, long-term trends, comparison to competitors
| Elevance Health Inc. | Abbott Laboratories | CVS Health Corp. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|---|
| Feb 20, 2025 | ||||||
| Feb 21, 2024 | ||||||
| Feb 15, 2023 | ||||||
| Feb 16, 2022 | ||||||
| Feb 18, 2021 | ||||||
| Feb 19, 2020 | ||||||
| Feb 20, 2019 | ||||||
| Feb 21, 2018 | ||||||
| Feb 22, 2017 | ||||||
| Feb 19, 2016 | ||||||
| Feb 24, 2015 | ||||||
| Feb 20, 2014 | ||||||
| Feb 22, 2013 | ||||||
| Feb 22, 2012 | ||||||
| Feb 17, 2011 | ||||||
| Feb 18, 2010 | ||||||
| Feb 19, 2009 | ||||||
| Feb 21, 2008 | ||||||
| Feb 26, 2007 | ||||||
| Feb 23, 2006 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Health Care Equipment & Services)
Elevance Health Inc., P/E, long-term trends, comparison to sector (health care equipment & services)
| Elevance Health Inc. | Health Care Equipment & Services | |
|---|---|---|
| Feb 20, 2025 | ||
| Feb 21, 2024 | ||
| Feb 15, 2023 | ||
| Feb 16, 2022 | ||
| Feb 18, 2021 | ||
| Feb 19, 2020 | ||
| Feb 20, 2019 | ||
| Feb 21, 2018 | ||
| Feb 22, 2017 | ||
| Feb 19, 2016 | ||
| Feb 24, 2015 | ||
| Feb 20, 2014 | ||
| Feb 22, 2013 | ||
| Feb 22, 2012 | ||
| Feb 17, 2011 | ||
| Feb 18, 2010 | ||
| Feb 19, 2009 | ||
| Feb 21, 2008 | ||
| Feb 26, 2007 | ||
| Feb 23, 2006 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Elevance Health Inc., P/E, long-term trends, comparison to industry (health care)
| Elevance Health Inc. | Health Care | |
|---|---|---|
| Feb 20, 2025 | ||
| Feb 21, 2024 | ||
| Feb 15, 2023 | ||
| Feb 16, 2022 | ||
| Feb 18, 2021 | ||
| Feb 19, 2020 | ||
| Feb 20, 2019 | ||
| Feb 21, 2018 | ||
| Feb 22, 2017 | ||
| Feb 19, 2016 | ||
| Feb 24, 2015 | ||
| Feb 20, 2014 | ||
| Feb 22, 2013 | ||
| Feb 22, 2012 | ||
| Feb 17, 2011 | ||
| Feb 18, 2010 | ||
| Feb 19, 2009 | ||
| Feb 21, 2008 | ||
| Feb 26, 2007 | ||
| Feb 23, 2006 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).